文献速递技术与安全PETCT

18F-FDG PET/CT预测实体瘤程序性死亡配体1(PD-L1)表达诊断试验准确性的Meta分析

Diagnostic test accuracy of 18F-FDG PET/CT for prediction of programmed death ligand 1 (PD-L1) expression in solid tumours: a meta-analysis.
PubMed 文献 · Clin Radiol · 2021-07-11

该系统评价与Meta分析纳入7项研究共473例患者,评估18F-FDG PET/CT预测非肺癌实体瘤PD-L1表达的诊断性能。汇总敏感度为0.75(95%CI:0.65-0.82),汇总特异度为0.73(95%CI:0.64-0.81),AUC为0.80(95%CI:0.77-0.84)。作者认为诊断准确性中等,现有文献有限,需进一步大型多中心研究证实。

要点

  • 18F-FDG PET/CT预测实体瘤PD-L1表达的汇总敏感度0.75、特异度0.73,AUC 0.80。
  • 汇总阳性似然比2.8、阴性似然比0.35,诊断比值比8。
  • 敏感度汇总无异质性(I²=47.2,p=0.08),特异度汇总有异质性(I²=53.8,p=0.04)。

核心结论

  • 当前Meta分析显示18F-FDG PET/CT预测实体瘤PD-L1表达的敏感度和特异度为中等水平;现有文献仍有限,需进一步大型多中心研究证实其诊断准确性。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、Cochrane和EMBASE数据库从建库至2020年10月31日,纳入评估18F-FDG PET/CT预测非肺癌实体瘤PD-L1表达诊断性能的研究,共7项研究473例患者。

诊断标准与关键数值

  • 18F-FDG PET/CT预测实体瘤PD-L1表达的汇总敏感度为0.75(95%CI:0.65-0.82),汇总特异度为0.73(95%CI:0.64-0.81)。
  • 汇总阳性似然比为2.8(95%CI:2.1-3.7),汇总阴性似然比为0.35(95%CI:0.26-0.47)。
  • 汇总诊断比值比为8(95%CI:5-13),分层汇总受试者工作特征曲线下面积为0.80(95%CI:0.77-0.84)。
  • 敏感度汇总无异质性(I²=47.2,p=0.08),特异度汇总有异质性(I²=53.8,p=0.04)。

局限性

  • 现有关于18F-FDG PET/CT预测实体瘤PD-L1表达的文献仍有限。
  • 需进一步大型多中心研究以证实18F-FDG PET/CT预测实体瘤PD-L1表达的诊断准确性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To investigate the predictive value of integrated 2-[18F]-fluoro-2-deoxy-d-glucose (18F-FDG) positron-emission tomography/computed tomography (PET/CT) for the prediction of programmed death ligand 1 (PD-L1) expression in solid tumours via a systematic review and meta-analysis.

MATERIALS AND METHODS: The PubMed, Cochrane, and EMBASE databases, from the earliest available date of indexing through 31 October 2020, were searched for studies evaluating the diagnostic performance of 18F-FDG PET/CT for prediction of PD-L1 expression in solid tumours other than lung cancer.

RESULTS: Across seven studies (473 patients), the pooled sensitivity for 18F-FDG PET/CT was 0.75 (95% confidence interval [CI]: 0.65-0.82) without heterogeneity (I2 = 47.2, p=0.08) and a pooled specificity of 0.73 (95% CI: 0.64-0.81) with heterogeneity (I2 = 53.8, p=0.04). Likelihood ratio (LR) syntheses gave an overall positive likelihood ratio (LR+) of 2.8 (95% CI: 2.1-3.7) and negative likelihood ratio (LR-) of 0.35 (95% CI: 0.26-0.47). The pooled diagnostic odds ratio (DOR) was 8 (95% CI: 5-13). Hierarchical summary receiver operating characteristic (ROC) curve and indicates that the area under the curve was 0.80 (95% CI: 0.77-0.84).

CONCLUSION: The current meta-analysis showed a moderate sensitivity and specificity of 18F-FDG PET/CT for the prediction of PD-L1 expression in solid tumours. At present, the literature regarding the use of 18F-FDG PET/CT for the prediction of PD-L1 expression in solid tumours still limited; thus, further large multicentre studies would be necessary to substantiate the diagnostic accuracy of 18F-FDG PET/CT for prediction of PD-L1 expression in solid tumours.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Seol HY, Kim YS, Kim SJ, et al. Diagnostic test accuracy of 18F-FDG PET/CT for prediction of programmed death ligand 1 (PD-L1) expression in solid tumours: a meta-analysis. Clin Radiol. 2021. PMID: 34261597. doi:10.1016/j.crad.2021.06.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。